Singapore To Make H1N1 Flu Shots Voluntary Amid Side Effect Concerns
This article was originally published in PharmAsia News
Executive Summary
Singapore, yet to feel the onslaught of the H1N1 influenza virus, has decided to make vaccinations voluntary. Once available, the vaccine is to be sold at general-practitioner clinics, similar to the way drugs against the seasonal flu are handled. The Ministry of Health said it decided to make the shots voluntary because the vaccine might have side effects not yet discovered. The ministry noted the 1976 problem in the United States when people developed Guillain-Barre syndrome after being given a vaccine rushed into use. (Click here for more
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.